Ritalin LA 40 mg Capsules Schweiz - Französisch - Swissmedic (Swiss Agency for Therapeutic Products)

ritalin la 40 mg capsules

novartis pharma schweiz ag - methylphenidati hydrochloridum - capsules - methylphenidati hydrochloridum 40 mg, sacchari sphaerae corresp. saccharum mg et saccharum max. 225.89 mg et maydis amylum, maydis amylum, macrogolum 6000, ammonio methacrylatis copolymerum b, acidi methacrylici copolymerum a, talcum, triethylis citras, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), e 172 (nigrum), e 172 (rubrum), drucktinte: pro capsula, lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 171, e 172 (rubrum), e 172 (flavum), pro capsula. - psychotonikum - synthetika

Ritalin LA 10 mg Capsules Schweiz - Französisch - Swissmedic (Swiss Agency for Therapeutic Products)

ritalin la 10 mg capsules

novartis pharma schweiz ag - methylphenidati hydrochloridum - capsules - methylphenidati hydrochloridum 10 mg, sacchari sphaerae corresp. saccharum max. 56.48 mg et saccharum mg et maydis amylum, maydis amylum, macrogolum 6000, ammonio methacrylatis copolymerum b, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, talcum, triethylis citras, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (nigrum), e 172 (rubrum), e 172 (flavum), e 172 (rubrum), e 172 (nigrum), drucktinte: drucktinte: lacca, lacca, propylenglycolum, propylenglycolum, kalii hydroxidum, ammoniae solutio 28 per centum, e 171, kalii hydroxidum, e 171, e 172 (rubrum), e 172 (rubrum), e 172 (flavum), e 172 (flavum), pro capsula, pro capsula. - psychotonikum - synthetika

Ritalin LA 60 mg Capsules Schweiz - Französisch - Swissmedic (Swiss Agency for Therapeutic Products)

ritalin la 60 mg capsules

novartis pharma schweiz ag - methylphenidati hydrochloridum - capsules - methylphenidati hydrochloridum 60 mg, sacchari sphaerae, macrogolum 6000, saccharum max. 338.85 mg et ammonio methacrylatis copolymerum b, maydis amylum, acidi methacrylici copolymerum a, talcum, triethylis citras, kapselhülle: gelatina, aqua, color.: e 171, e 172, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 171, e 172 (rubrum), e 172 (flavum), pro capsula. - psychotonikum - synthetika

Naelia Vaginalring Schweiz - Französisch - Swissmedic (Swiss Agency for Therapeutic Products)

naelia vaginalring

mepha pharma ag - etonogestrelum, ethinylestradiolum - vaginalring - etonogestrelum 11,7 mg, ethinylestradiolum 2,7 mg, excipiens pour la préparation. - hormonale de contraception - synthetika

Methylphenidat-Mepha LA 10mg Depocaps Schweiz - Französisch - Swissmedic (Swiss Agency for Therapeutic Products)

methylphenidat-mepha la 10mg depocaps

mepha pharma ag - methylphenidati hydrochloridum - depocaps - methylphenidati hydrochloridum 10 mg, excipiens pro de la capsule. - psychotonikum - synthetika

Methylphenidat-Mepha LA 20mg Depocaps Schweiz - Französisch - Swissmedic (Swiss Agency for Therapeutic Products)

methylphenidat-mepha la 20mg depocaps

mepha pharma ag - methylphenidati hydrochloridum - depocaps - methylphenidati hydrochloridum 20 mg, excipiens pro de la capsule. - psychotonikum - synthetika

Methylphenidat-Mepha LA 30mg Depocaps Schweiz - Französisch - Swissmedic (Swiss Agency for Therapeutic Products)

methylphenidat-mepha la 30mg depocaps

mepha pharma ag - methylphenidati hydrochloridum - depocaps - methylphenidati hydrochloridum 30 mg, excipiens pro de la capsule. - psychotonikum - synthetika

Methylphenidat-Mepha LA 40mg Depocaps Schweiz - Französisch - Swissmedic (Swiss Agency for Therapeutic Products)

methylphenidat-mepha la 40mg depocaps

mepha pharma ag - methylphenidati hydrochloridum - depocaps - methylphenidati hydrochloridum 40 mg, excipiens pro de la capsule. - psychotonikum - synthetika

Gencebok Europäische Union - Französisch - EMA (European Medicines Agency)

gencebok

gennisium pharma - du citrate de caféine - l'apnée - psychoanaleptics, - le traitement primaire de l'apnée du sommeil des nouveau-nés prématurés.

Fintepla Europäische Union - Französisch - EMA (European Medicines Agency)

fintepla

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - des antiépileptiques,des - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.